Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage†
Version of Record online: 9 NOV 2009
Copyright © 2010 American Association for the Study of Liver Diseases
Volume 51, Issue 4, pages 1185–1189, April 2010
How to Cite
Wu, I.-C., Lai, C.-L., Han, S.-H. B., Han, K.-H., Gordon, S. C., Chao, Y.-C., Tan, C.-K., Sievert, W., Tanwandee, T., Xu, D., Neo, B.-L. and Chang, T.-T. (2010), Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage. Hepatology, 51: 1185–1189. doi: 10.1002/hep.23424
Potential conflict of interest: Dr. Lai is a consultant for, advises, and is on the speakers' bureau of Bristol-Myers Squibb. Dr. S. Han is on the speakers' bureau of and received grants from Bristol-Myers Squibb. Dr. K. Han advises Bristol-Myers Squibb. Dr. Sievert is on the speakers' bureau of Bristol-Myers Squibb. Drs. Xu and Neo own stock in Bristol-Myers Squibb. Dr. Chang received grants from Bristol-Myers Squibb.
- Issue online: 26 MAR 2010
- Version of Record online: 9 NOV 2009
- Accepted manuscript online: 9 NOV 2009 12:00AM EST
- Manuscript Accepted: 30 OCT 2009
- Manuscript Received: 7 JAN 2009
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.